loncastuximab tesirine
galiximab
afutuzumab
axicabtagene ciloleucel
ibritumomab tiuxetan
tabalumab
tigatuzumab
mosunetuzumab
acalabrutinib
acrixolimab
tositumomab
mogamulizumab
ramucirumab
duligotuzumab
onartuzumab
tenatumomab
umbralisib
inotuzumab
cixutumumab
isatuximab
ozoralizumab
brentuximab vedotin
sotrovimab
indatuximab ravtansine
rituximab
fontolizumab
alsevalimab
lintuzumab
sibrotuzumab
DLBCL
matuzumab
-les-
oportuzumab monatox
imdevimab
alemtuzumab
durvalumab
atezolizumab
alacizumab
panitumumab
immunotherapeutic
natalizumab
oleclumab
talizumab
conatumumab
milatuzumab
naptumomab estafenatox
pegaspargase
veltuzumab
tafasitamab
Waldenström's macroglobulinemia